NCT06390553

Brief Summary

This study was planned to investigate the use and results of virtual reality applications with specially prepared software for the rehabilitation of freezing phenomenon, which increases the falling anxiety of individuals with Parkinson's disease and causes social isolation. Individuals over the age of 50 who have been diagnosed with idiopathic Parkinson's disease by a specialist neurologist will be included in the study; Individuals evaluated in terms of balance, functional mobility, freezing phenomenon, participation, and cognitive status will be randomly divided into two groups receiving conventional treatment and additional virtual reality. After the preliminary evaluation, they will receive 8 weeks of treatment 4 days a week and will be evaluated after the treatment and 3 months after the treatment. In addition to the improvements that will emerge as a result of the treatments within the scope of the study, it is expected that the virtual reality application created with crowd simulation will provide more effective results in improving the parameters. Knowing the effects of exercises in crowds, which cannot be performed in the clinic, in the treatment of Parkinson's disease patients, whose freezing and freezing-related symptoms are aggravated, especially in crowded environments, will make significant contributions to the field.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 19, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 30, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

1.5 years

First QC Date

April 19, 2024

Last Update Submit

April 26, 2024

Conditions

Keywords

virtual realityrehabilitation

Outcome Measures

Primary Outcomes (5)

  • Freezing Phenomenon

    The presence and severity of freezing in patients will be evaluated with the Freezing of Gait Questionnaire. It consists of six items and each item is evaluated with a 5-point Likert scale. In the scale, which was adapted into Turkish by Candan et al., the score range is 0-24 and high scores indicate that the condition associated with frostbite is poor.

    Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  • Balance

    The balance of the patients will be evaluated with the Biodex Balance System. Postural stability and fall risk will be evaluated.

    Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  • Functional Mobility

    The Timed Get Up and Go Test (TUG) will be used to assess functional mobility. The TUG, which includes walking and turning functions, has been shown to be highly reliable and valid for individuals with Parkinson's disease). The person to be tested sits on a chair at normal height. With the command "Go", the person is asked to get up from the chair and walk 3 m forward at a normal walking speed and then return and sit back on the chair. It is usually administered twice and the average time is recorded. The person is allowed to use an assistive device (if available) and this is noted.

    Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  • Quality of Life Assessment

    Quality of life will be assessed with Parkinson's Disease Questionnaire (PDQ-8) developed specifically for individuals with Parkinson's disease. This validated questionnaire consists of eight questions to assess mobility, activities of daily living, emotional well-being, disease stigma, social support, cognition, communication and physical discomfort . In the questionnaire, the status of the person in the last month is questioned. The total score is between 0 and 100, with lower scores indicating better perceived health status due to the disease.

    Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  • Participation

    In order to evaluate social participation in the study, home participation (grocery shopping, meal preparation, daily household chores, money management, etc.), social participation (hobby, going out of the house, etc.), productivity (school, work, volunteer activities, etc.), electronic A scale consisting of 43 social networks (internet use, social communication, mobile phone use, etc.), 4 subunits and a total of 18 questions will be used.

    Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

Secondary Outcomes (2)

  • Executive functions

    Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  • The activity-specific balance confidence scale

    Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

Study Arms (2)

Conventional group

ACTIVE COMPARATOR

Patients in the conventional treatment group will be given 15 minutes of walking training in addition to the 45 minutes of conventional Parkinson's rehabilitation program. Patients in the conventional treatment group will be trained in flexibility (lumbar extensors, hip flexors, hamstrings, pectorals), balance (weight transfer, static balance with stress loading) coordination (rotational and bilateral activities), respiratory (thoracic expansion, respiratory control), strength (hip circumference, abdomen, back extensors), stabilization, posture (chin tuck, scapular adduction) exercises will be given and the number of repetitions will be adjusted according to patient performance. Walking training to be given to the conventional group will include walking in different directions, walking with arm swing, walking over blocks, stopping and restarting walking, and changing direction activities.

Procedure: Conventional Parkinson Rehabilitation

Virtual reality group

EXPERIMENTAL

Patients in the virtual reality group will be given a 45-minute conventional Parkinson's rehabilitation program similar to those in the conventional group, followed by 15 minutes of virtual reality walking training. Patients in the virtual reality group will be trained in flexibility (lumbar extensors, hip flexors, hamstrings, pectorals), balance (weight transfer, static balance with stress loading) coordination (rotational and bilateral activities), Respiratory (thoracic expansion, respiratory control), strength (hip circumference, abdomen, back extensors) stabilization, posture (chin tuck, scapular adduction) exercises will be given and the number of repetitions will be adjusted according to patient performance. Virtual reality applications increase the sense of reality in the individual with enriched virtual environments where sensory inputs are increased and provide the opportunity to perform activity training with a rich variety of tasks.

Device: Task-Oriented Virtual Reality Application with Crowd SimulationProcedure: Conventional Parkinson Rehabilitation

Interventions

Patients will be treated 4 days a week for 8 weeks in accordance with their assigned group.

Virtual reality group

Patients will be treated 4 days a week for 8 weeks in accordance with their assigned group.

Conventional groupVirtual reality group

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being diagnosed with Parkinson's disease by a qualified neurologist (diagnosed with idiopathic PD according to UK Brain Bank criteria
  • Being between 1-2.5 stages according to the Hoehn and Yahr Staging Scale
  • Volunteering to participate in the study
  • years of age or older
  • Standardized Mini Mental Test score greater than 24
  • Patients experiencing an on-off period are in the "on" period
  • Not using deep brain stimulation or drug pump
  • Ability to walk independently on level ground (Functional Ambulation 3 and above according to classification)
  • Having a score of (≥2) on item 3 of the freezing while walking scale

You may not qualify if:

  • Being any neurological or psychiatric disease other than Parkinson's disease
  • Cardiovascular, vestibular or musculoskeletal disease
  • Dyskinetic movements
  • Having vision problems that cannot be corrected with glasses or lenses
  • Hearing problems that cannot be corrected with a hearing aid
  • Using an assistive device

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Gazi University

Ankara, Maltepe, 06570, Turkey (Türkiye)

Location

Kirsehir Ahi Evran University

Kirşehi̇r, Merkez, 40100, Turkey (Türkiye)

Location

Ankara Yildirim Beyazit University

Ankara, Çubuk, 06760, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Ertuğrul DEMİRDEL, Assoc. Prof.

    Ankara Yildirim Beyazıt University

    STUDY DIRECTOR
  • Özge BARUT ÇELİK, MSc.

    Kirsehir Ahi Evran University

    STUDY CHAIR
  • Figen TUNCAY, Prof.

    Kirsehir Ahi Evran University

    PRINCIPAL INVESTIGATOR
  • Öner BARUT, Asst. Prof.

    Gazi University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ertuğrul DEMİRDEL, Assoc. Prof.

CONTACT

Özge BARUT ÇELİK, MSc.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

April 19, 2024

First Posted

April 30, 2024

Study Start

August 1, 2024

Primary Completion

February 1, 2026

Study Completion

April 1, 2026

Last Updated

April 30, 2024

Record last verified: 2024-04

Locations